| 08:00-08:45 | Registration Open / Arrival Tea and Coffee |
| 08:45-09:15 | OPENING OF THE CONGRESS
Chair: Alberico Catapano (IT), Gustavs Latkovskis (LV), Béla Merkely (HU),
Margus Viigimaa (EE)
Welcome speech by Mr. Jüri Ratas, Prime Minister of Republic of Estonia |
| 09:15-10:45 | PLENARY SESSION I
Lipid management in secondary prevention of cardiovascular disease
Baltic Atherosclerosis Society – European Atherosclerosis Society joint session
Chair: Maciej Banach (PL), Alberico Catapano (IT), Margus Viigimaa (EE)
- Lipid-lowering therapy: present and future developments. Keynote lecture. Alberico Catapano (IT)
- Novel pathways of atherogenesis and challenging therapeutic targets. Rimvydas Slapikas (LT)
- Statin intolerance definition, diagnosis and management in 2018. Maciej Banach (PL)
- Current development of lipid management in Baltic countries. Margus Viigimaa (EE)
|
| 10:45-11:15 | Coffee break, Press conference |
| 11:15-12:30 | PLENARY SESSION II
Cardiovascular Risk in Diabetes
Chair: Peter Nilsson (SE), Lars Rydén (SE), Vallo Volke (EE)
- Cardiovascular outcome trials in type 2 diabetes. Lessons learned from the perspective of a cardiologist. Keynote lecture. Lars Rydén (SE)
- Antidiabetic drugs and cardiovascular risk – endocrinologist’s point of view. Vallo Volke (EE)
- Cardiovascular risk management in diabetes and hypertension. Peter Nilsson (SE)
|
| 12:30-13:30 | Lunch |
| 13:30-15:10 | Satellite Symposia |
| 13:30-14:15 | AMGEN
Integrating anti-PCSK9 therapy into secondary prevention of CVD
Chair: Chair: Margus Viigimaa (EE), Gustavs Latkovskis (LV)
- Role of PCSK9 inhibition in secondary prevention.Alberico Catapano (IT)
- FOURIER: PCSK9 inhibition decreases CV events in high-risk patients. Terje Pedersen (NO)
- Effectiveness and safety of very low LDL-c values with evolocumab: lowest is best. Alberico Catapano (IT)
- Which patients could benefit from treatment in clinical practice? Alberico Catapano (IT)
|
| 14:20-15:05 | Berlin-Chemie Menarini
Chair: Chair: Margus Viigimaa (EE)
Invitation to Berlin-Chemie Menarini Satellite Symposia in PDF-format.
- The newest guidelines on hypertension: focus on tight blood pressure control. Margus Viigimaa (EE)
- Uncontrolled hypertension – time to act. Lessons learned from case studies. Kārlis Trušinskis (LV)
- Discussion
|
| 15:10-16:40 | PLENARY SESSION III
Atherosclerosis and heart
Baltic Atherosclerosis Society – European Society of Cardiology joint session
Chair: Béla Merkely (HU), Aleksandras Laucevicius (LT), Terje Pedersen (NO)
- Lipid-lowering therapy in the future: Will statins still be the basis? Terje Pedersen (NO)
- Prevention of sudden cardiac death - the role of implantable devices. Béla Merkely (HU)
- Is metabolic syndrome high or moderate cardiovascular (cardiometabolic) risk entity: results of Lithuanian High Cardiovascular Risk (LitHiR) programme. Aleksandras Laucevicius (LT)
- How to improve BP Control? Novel Initiatives. Serap Erdine (TR)
- Discussion
|
| 16:40-17:00 | Coffee break |
| 17:00-18:40 | Satellite Symposia |
| 17:00-17:45 | Boehringer Ingelheim
Anticoagulation Management In Special Situations- Innovative or Conservative Treatment?
Invitation to Boehringer Ingelheim Satellite Symposia in PDF-format.
- Rewire your thinking on AF ablation. Kārlis Trusinskis (LV)
- Improving care decisions after coronary revascularization. Elena Baranova (RUS)
|
| 17:50-18:35 | AstraZeneca
Treat to success or treat to failure. What does real life tell us about Type 2 DM?
Invitation to AstraZeneca Satellite Symposia in PDF-format.
Chair: Kārlis Trusinskis (LV), Kristīne Ducena (LV) |
| 18:40-19:50 | PARALLEL SESSION I
Familial hypercholesterolemia
Chair: Gustavs Latkovskis (LV), Michal Vrablik (CZ)
- Three-year experience of the Latvian Registry of Familial Hypercholesterolemia: challenges and achievements. Gustavs Latkovskis (LV)
- Familial hypercholesterolemia screening: International and national initiatives.
Žaneta Petrulionienė (LT)
- FH management: expectations and reality. Michal Vrablik (CZ)
- Discussion: Familial Hypercholesterolemia registries in Europe and in Baltic countries
|
| 18:40-19:50 | PARALLEL SESSION II
Coronary atherosclerosis: physiology and management
Chair: Sergei Nazarenko (EE), Kārlis Trušinskis (LV)
- Vascular restoration therapy: the role of intravascular imaging guided plaque modification prior drug eluting stent or bioresorbable scaffold implantation. Andrejs Ērglis (LV)
- Vascular Protection by Factor Xa Inhibition in Patients with Coronary and/or Peripheral Artery Disease. Kārlis Trusinskis (LV)
- Role of 18F-FDG-PET/CT in Management of Atherosclerotic Plaque: Current Evidence. Sergei Nazarenko (EE)
|
| 20:00-22:00 | Welcome reception at Valuutabaar (Hard Currency Bar), Congress Venue |
| 09:00-10:00 | PLENARY SESSION IV
Cardiovascular risk factors and management
Chair: Irina Chazova (RU), Iveta Mintāle (LV)
- Impact of chronic stress on atherosclerosis process. Dovile Karciauskaite (LT)
- Arterial hypertension and atherosclerosis: data from Russian national registry. Irina Chazova (RU)
- Lifestyle management in cardiovascular prevention. Iveta Mintāle (LV)
|
| 10:00-11:20 | PLENARY SESSION V
Goals in blood pressure, lipids and glucose. Are we treating well?
Chair: Serap Erdine (TR), Andrejs Ērglis (LV), Rimvydas Slapikas (LT)
- Goals in blood pressure. Peter Nilsson (SE)
- Goals in lipids. Gustavs Latkovskis (LV)
- Goals in glucose. Mart Roosimaa (EE)
|
| 11:00-11:20 | Coffee break |
| 11:20-11:50 | PLENARY SESSION VI
History of the Baltic Society of Atherosclerosis. General Assembly
Chair: Zita Kučinskienė (LT), Gustavs Latkovskis (LV), Margus Viigimaa (EE) |
| 11:50-12:50 | PLENARY SESSION VII
Personalised diagnostics and treatment of atherosclerotic disease
Chair: Valdis Pīrāgs (LV), Peeter Ross (EE)
- From Biobanking to Precision Medicine and beyond: the Estonian Experience. Andres Metspalu (EE)
- Using the principles of stratified medicine to individualize treatment strategies for diabetic patients. Experience from the Latvian Genome Data Base. Valdis Pīrāgs (LV)
- Importance of data quality in nation-wide e-health system for personalized medicine decision support applications. Peeter Ross (EE)
|
| 12:50-13:00 | Closing remarks |
| 13:00 | Say Goodbye Coffee |
